CHD7 and CHARGE syndrome: It has been previously described that CHD7 can bind to the p53 promoter, thereby negatively regulating p53 expression, and that CHD7 loss in mouse neural crest cells or samples from patients with CHARGE syndrome results in p53 activation (Van Nostrand et al., 2014).